CJC-1295 and Ipamorelin together
This blend pairs two peptides that act on different parts of the growth hormone axis: CJC-1295, a modified analog of growth hormone-releasing hormone (GHRH), and Ipamorelin, a pentapeptide that acts as a selective agonist at the ghrelin receptor (GHS-R1a).
Why the two are studied together
Because GHRH analogs and ghrelin-receptor agonists act on separate receptors, researchers often study them in combination to examine how the two signaling pathways interact. Our guide Growth Hormone-Releasing Peptides Explained covers the biology behind both peptide classes, including the difference between CJC-1295 with and without DAC, and Peptide Blends Explained covers how to evaluate a combined preparation like this one.
Quality and handling
Each component should carry its own identity and purity evidence; see how to read a certificate of analysis. Store the lyophilized material as described in our storage and handling guide.
This product is supplied strictly for laboratory research use only. It is not approved for human or animal use, and Peptide Warehouse does not provide dosing or administration guidance.
Related research compounds
CJC-1295 (No DAC) · CJC-1295 w/ DAC · Ipamorelin · Tesamorelin + Ipamorelin Blend · Sermorelin
Documentation and methods
Analytical testing · How to read a COA · Storage and handling · What are research peptides



